gvtcx

Blood product required for the treatment of TTP patients

University Hospitals of Leicester NHS Trust Published 3 Aug 2022 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Statuscomplete
Category (CPV) 33141510
RegionEast Midlands
Deadline1 Jun 2022
Contract start1 Jul 2022
Contract end30 Jun 2024
Procedureselective
SME suitableNo
OCIDocds-b5fd17-28db2e69-fd8d-4b0e-9e35-ce247ea6a2a5

Award

SupplierValueDateStatus
Octapharma Limited £97,500 1 Aug 2022 active

description

Octaplas, blood product required for the treatment of TTP patients.

CMU National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B

Offer reference number: CM/PHS/19/5576

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
3 Aug 2022 Award (award) · 1c3e34fb-ff9b-43bb-9849-8acce6ae1cbe-560150

more from University Hospitals of Leicester NHS Trust

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.